Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Hogy Medical Co ( (JP:3593) ) has provided an announcement.
Hogy Medical Co., Ltd. announced a significant change in its leadership structure, with Taisuke Fujita being appointed as the new Representative Director and Vice President, effective June 20, 2025. This strategic move aims to strengthen the company’s management framework, potentially impacting its operational efficiency and market positioning. Additionally, the company will see the resignation of two outside directors, Kiyoshi Uesugi and Yuta Kinose, on the same date.
The most recent analyst rating on (JP:3593) stock is a Hold with a Yen3700.00 price target. To see the full list of analyst forecasts on Hogy Medical Co stock, see the JP:3593 Stock Forecast page.
More about Hogy Medical Co
Hogy Medical Co., Ltd. operates in the medical industry, focusing on providing healthcare products and services. The company is listed on the Tokyo Stock Exchange, Prime Market, and is known for its commitment to enhancing its management structure and market presence.
Average Trading Volume: 63,000
Technical Sentiment Signal: Hold
Current Market Cap: Yen58.77B
For detailed information about 3593 stock, go to TipRanks’ Stock Analysis page.